Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis

Efficacy of conventional chemoimmunotherapy is limited in patients with Richter syndrome (RS) with anticipated median overall survival (OS) of less than 10 months. Allogeneic hematopoietic cell transplantation (allo-HCT) is commonly offered as a consolidative treatment option in RS. To our knowledge...

詳細記述

保存先:
書誌詳細
出版年:Hematol Oncol Stem Cell Ther
主要な著者: Aulakh, Sonikpreet, Reljic, Tea, Yassine, Farah, Ayala, Ernesto, Chavez, Julio C., Chanan-Khan, Asher, Pinilla-Ibarz, Javier, Kumar, Ambuj, Kharfan-Dabaja, Mohamed A.
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7666647/
https://ncbi.nlm.nih.gov/pubmed/32473105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hemonc.2020.05.002
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料